Friday, March 15, 2013
Thursday, March 14, 2013
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Impact of superovulation for women with endometriosis |4483060
Obstetrics & Gynecology - Repro Endo - Infertility News Article | Impact of superovulation for women with endometriosis |4483060
Kavoussi SK – Superovulation (SO)/Intrauterine insemination (IUI) has been used as a treatment approach for endometriosis–associated infertility. The existing medical literature regarding SO in endometriosis patients is composed of heterogeneous studies that differ in terms of study design, SO protocols, the addition of IUI, and comparison groups. There is a need for more well–designed studies to further investigate the efficacy of SO in women with endometriosis–associated infertility. Although in vitro fertilization (IVF) is most effective and is significantly superior to other treatments in endometriosis patients, most of the existing studies suggest some benefit of SO/IUI in infertility patients with early–stage disease. Therefore, SO/IUI is a reasonable early fertility treatment option for women with endometriosis who desire a short trial of potentially more cost–effective treatment options prior to pursuing an IVF cycle and those for whom IVF is not a feasible or desirable option. It appears that gonadotropins are most effective for SO in this patient population even though more head–to–head comparisons are needed.
Kavoussi SK – Superovulation (SO)/Intrauterine insemination (IUI) has been used as a treatment approach for endometriosis–associated infertility. The existing medical literature regarding SO in endometriosis patients is composed of heterogeneous studies that differ in terms of study design, SO protocols, the addition of IUI, and comparison groups. There is a need for more well–designed studies to further investigate the efficacy of SO in women with endometriosis–associated infertility. Although in vitro fertilization (IVF) is most effective and is significantly superior to other treatments in endometriosis patients, most of the existing studies suggest some benefit of SO/IUI in infertility patients with early–stage disease. Therefore, SO/IUI is a reasonable early fertility treatment option for women with endometriosis who desire a short trial of potentially more cost–effective treatment options prior to pursuing an IVF cycle and those for whom IVF is not a feasible or desirable option. It appears that gonadotropins are most effective for SO in this patient population even though more head–to–head comparisons are needed.
Obstetrics & Gynecology News Article | Noninvasive screening tools for Down syndrome: a review |4509955
Obstetrics & Gynecology News Article | Noninvasive screening tools for Down syndrome: a review |4509955
Smith M and Visootsak J.– This review summarizes all currently available noninvasive diagnostic techniques for the detection of Down syndrome.Down syndrome is the leading cause of prenatal chromosome abnormalities, accounting for 53% of all reported chromosome conditions. Testing strategies, guidelines, and screening options have expanded from their conception in the 1970s, and now include such options as anatomical ultrasound, maternal serum screening, and noninvasive prenatal testing. By understanding fully each technology and the possible alternatives, the physician will be able to provide their patients with all the information necessary to make an informed decision regarding their medical management.
Smith M and Visootsak J.– This review summarizes all currently available noninvasive diagnostic techniques for the detection of Down syndrome.Down syndrome is the leading cause of prenatal chromosome abnormalities, accounting for 53% of all reported chromosome conditions. Testing strategies, guidelines, and screening options have expanded from their conception in the 1970s, and now include such options as anatomical ultrasound, maternal serum screening, and noninvasive prenatal testing. By understanding fully each technology and the possible alternatives, the physician will be able to provide their patients with all the information necessary to make an informed decision regarding their medical management.
Obstetrics & Gynecology - Popular Press News Article | Omega-3 DHA may prevent earliest preemies |4507708
Obstetrics & Gynecology - Popular Press News Article | Omega-3 DHA may prevent earliest preemies |4507708
For pregnant women, supplements of an omega–3 fatty acid called Docosahexaenoic acid (DHA) may help to reduce the likelihood of giving birth very prematurely, according to a new study. The results add to evidence that omega–3 fatty acid supplements make pregnancy last a little longer, which means more development time for babies before birth, less hospital time after birth and a better long–term health outlook.
For pregnant women, supplements of an omega–3 fatty acid called Docosahexaenoic acid (DHA) may help to reduce the likelihood of giving birth very prematurely, according to a new study. The results add to evidence that omega–3 fatty acid supplements make pregnancy last a little longer, which means more development time for babies before birth, less hospital time after birth and a better long–term health outlook.
Subscribe to:
Posts (Atom)
Posts
